INTRODUCTION ABOUT GLIMDA MV 2MG TABLET
GLIMDA
MV 2MG TABLET is a combination of Glimepiride, Metformin and Voglibose,
which belongs to the group of medicines called Antidiabetic agents.
GLIMDA MV 2MG TABLET is used in adults to manage type 2 diabetes
mellitus when diet, exercise, and single-agent or second-line therapy
with two drugs are insufficient to adequately control blood sugar
levels.
GLIMDA MV 2MG TABLET is not recommended for use in
patients allergic to glimepiride, metformin, voglibose, and/or other
sulfonylureas or sulphonamides. It is also not recommended for use in
patients with acute conditions (such as dehydration or severe
infection), severe ketosis (a severe complication of diabetes), severe
trauma, lung problems (such as acute or chronic respiratory failure),
heart problems (such as acute or chronic cardiac failure or recent
myocardial infarction), and/or severe kidney or liver problems.
Before
taking GLIMDA MV 2MG TABLET, inform your doctor if you recently had
trauma and/or have febrile infections, fever, uncontrolled diabetes,
hypothyroidism (underactive thyroid), chronic intestinal disease, fever,
or other kidney or liver problems.
GLIMDA MV 2MG TABLET is not
recommended for use in pregnant and breastfeeding women since it may
cause harm to the developing foetus or nursing child.
GLIMDA MV
2MG TABLET is also not recommended for use in children and adolescents
(aged below 18 years) and is advised to be used with caution in elderly
patients (aged 75 years or older) after consulting the doctor.
The
most common side effects of GLIMDA MV 2MG TABLET are nausea and
vomiting, diarrhea, abdominal pain, loss of appetite, metallic taste,
and/or hypoglycemia (low blood sugar). Consult your doctor if any of
these side effects worsen.
| Weight | 17.5 g |
|---|
Shipping Policy
free Shipping
General Inquiries
There are no inquiries yet.
Related products
Customer reviews
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.